SCHEMBL1286436

SCHEMBL1286436

CC(C)(C)C(O)(CCCCOc1ccc(F)cc1F)Cn1cncn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 12/20 0.52
CYP2C9 P11712 10/20 0.52
CYP2C19 P33261 10/20 0.52
LMNA P02545 2/20 0.52
HSP90AA1 P07900 1/20 0.52
CYP19A1 P11511 1/20 0.52
CYP11B1 P15538 1/20 0.52
CYP11B2 P19099 1/20 0.52
ADRA1A P35348 1/20 0.52
CYP51A1 Q16850 1/20 0.52
MAPK1 P28482 2/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP2B6 P20813 1/20 0.46
CYP3A5 P20815 1/20 0.46
CYP3A7 P24462 1/20 0.46
CYP3A43 Q9HB55 1/20 0.46
CYP46A1 Q9Y6A2 1/20 0.46
KMT2A Q03164 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2128040 0.89 MAPK1 (0.63) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL1286480 0.81 ALDH1A1 (0.60) CYP3A4CYP2C19LMNAALDH1A1KMT2A
SCHEMBL1286485 0.81 ALDH1A1 (0.57) CYP3A4CYP2C19HSP90AA1MAPK1ALDH1A1
SCHEMBL1281730 0.80 HSP90AB1 (0.32) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL1281978 0.79 HSP90AB1 (0.32) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL1282665 0.78 ALDH1A1 (0.55) CYP3A4LMNAHSP90AA1ALDH1A1KMT2A
SCHEMBL2125400 0.78 CYP3A4 (0.68) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL10368324 0.77 CYP3A4 (0.50) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL10392892 0.77 ALDH1A1 (0.61) CYP3A4CYP2C19LMNAALDH1A1KMT2A
SCHEMBL1282161 0.77 HSP90AB1 (0.33) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443098-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2012-04-25 EP disclosed
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives BASF SE (DE) 2012-04-12 US disclosed
WO-2010146112-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives ERG28, CYP51A1, DPM1 CYP3A4 19/4885CYP2C9 77/4885CYP2C19 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.